Carcinoembryonic Antigen Market to grow at 6% CAGR from 2016 to 2023

1
Carcinoembryonic Antigen Market to reach 2.7bn
by 2023 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Carcinoembryonic Antigen
Market

• Continuous advancement in technology in the
  development of new biomarkers which is used in
  combination with other biomarkers is anticipated
  to accelerate carcinoembryonic antigen market
  demand over the forecast period.
• Global Market Insights, Inc. says (CEA)
  Carcinoembryonic Antigen Market size is expected
  to exceed USD 2.7 billion by 2023 according to a
  new research report by Global Market Insights,
  Inc.
• The benefits associated with minimally invasive
  diagnostics practice include higher patient
  satisfaction as they need minor incision
  injuries. Furthermore, these procedures comprise
  less hospital stay and hence, are economically
  feasible and involve fewer post procedure
  difficulties.
• The development of new immunological procedure
  such as radioimmunoassay is expected to increase
  the demand for the CEA market over the forecast
  timeframe.

3
Continued...

• Colorectal cancer application segment generated
  major revenue share of over 40 in the
  carcinoembryonic antigen market, and is estimated
  to exceed USD 1 billion by 2023.
• Breast cancer is rapidly growing application
  segment and it is anticipated to grow at a CAGR
  of 7.4 by 2023.
• Latin America accounted for over 5.01 of the
  global industry share in 2015. Changing
  lifestyle, excessive smoking and alcohol
  consumption are driving the industry growth in
  the region.
• North America led by U.S. carcinoembryonic
  antigen market accounted for over 75 revenue
  share in 2015, due to high patient awareness
  levels, high incidence rates of cancer and
  existence of sophisticated healthcare
  infrastructure in the region.
• Europe CEA market, was dominated by Germany with
  over USD 100 million revenue.

4
Germany Carcinoembryonic Antigen (CEA) Market
size, by application, 2012-2023 (USD Million)

5
Browse Full Market Research Report On
Carcinoembryonic Antigen Market _at_
http//bit.ly/2pqae1Q Request for a Sample
of this Research Report _at_ https//www.gminsights.c
om/request-sample/detail/427 https//www.gminsigh
ts.com/request-sample/detail/49
6
Continued...

• Asia Pacific carcinoembryonic antigen market
  share will witness significant gain growing at
  7.5 CAGR.
• Breast cancer is forecast to exceed USD 466
  million by 2023. Due to the rising number of
  female population, growing need for Hormone
  Replacement Therapy (HRT) and cosmetic surgeries.
  
• Industry participants in the CEA market include
  Abbott Diagnostics, Roche Diagnostics, Quest
  Diagnostics and GenWay Biotech.

7
Stay In Touch Website www.gminsights.com Soci
al Media